Investment Banking Experience Combined with Deep Biotech Knowledge
Biotech Alliances International provides sector specific strategic advise and financial services. We pride ourselves on prividing a level of expertise and customization that clients won’t find elsewhere.
Our extensive network of private equity, venture capital, and strategic investors allows us to tap into a broad pool of financing options and opportunities in the US & Europe.
We focus on capital and debt raising transactions ranging from $10 million to $50 million for growth capital, working capital, assets and acquisitions.
Strategic Partnerships: At the core of our capital raising strategy is our focus on presenting alternatives to traditional approaches to raising capital, including advising on strategic partnerships that can dramatically increase the company’s value beyond the equity investment.
We provide consulting services to emerging-growth companies, our knowledge base yields valuable insights to the planning, execution and post-transaction processes.
Today’s pharmaceutical, biotech and medical device companies face more formidable challenges than ever.
These challenges require deep insight, expert strategic capabilities, and deep scientific expertise.
Consulting effectively helps our clients solve their toughest problems based on content expertise, focus and breadth of experience.
Merger & Acquisition
We differentiate ourselves through our US, EU & Asia cross-border capabilities. Close coordination between our US, EU and Asian partners, allows us to represent companies to buyers in the US, EU and Asia.
We have a strong network of proven specialists who analyze opportunities and help implement initiatives around the globe.
By leveraging the knowledge of our investment banking team and our Consulting group, we provide enhanced M&A capabilities designed to optimize shareholder value.
Partnership & Licensing
We assist clients in developing and implementing strategies to acquire, develop, protect, enforce and commercialize intellectual property and technology.
Most emerging life science companies rely on partnerships with larger companies for late clinical development, regulatory affairs, manufacturing and marketing.
We advise our clients as they structure and negotiate corporate partnering and strategic alliance transactions, R&D deals, licensing arrangements, marketing arrangements, OEM agreements, distribution/agency contracts, and joint ventures.[ Meet the TEAM ]